Highly dispersed nano-enzyme triggered intracellular catalytic reaction toward cancer specific therapy. (November 2020)
- Record Type:
- Journal Article
- Title:
- Highly dispersed nano-enzyme triggered intracellular catalytic reaction toward cancer specific therapy. (November 2020)
- Main Title:
- Highly dispersed nano-enzyme triggered intracellular catalytic reaction toward cancer specific therapy
- Authors:
- Mei, Xuan
Hu, Tingting
Wang, Hui
Liang, Ruizheng
Bu, Wenbo
Wei, Min - Abstract:
- Abstract: Currently, reactive oxygen species (ROS)-induced apoptosis systems have drawn increasing attention in cancer therapy, owing to their specific tumor inhibition ability and great biocompatibility. Herein, we developed a highly dispersed nano-enzyme based on the assembly of natural glucose oxidase (GOD) onto CoFe-layered double hydroxides (CoFe-LDHs) monolayer nanosheets. By virtue of the high dispersion of Fe 3+ within the host layer, the CoFe-LDHs nanosheets exhibit a collaborative enhanced Fenton catalytic activity with a rate constant of 3.26 × 10 −4 s −1, which is 1–3 orders of magnitude higher than other iron-containing Fenton reaction agents. Subsequently, with a massive H2 O2 triggered by GOD, GOD/CoFe-LDHs nanohybrid converts a cascade of glucose into hydroxyl radicals under tumor acid conditions, which is validated by a high maximum velocity ( V max = 2.23 × 10 −6 M) and low Michaelis–Menten constant ( K M = 5.40 mM). Through the intracellular catalytic Fenton reaction within the tumor environment, both in vitro and in vivo results demonstrate the excellent antitumor effect of GOD/CoFe-LDHs. Therefore, a self-supplied, ultra-efficient and sequential catalytic tumor-specific therapy has been achieved based on GOD/CoFe-LDHs nano-enzyme, which holds great promise in clinical cancer therapy with minimum side effects. Graphical abstract: Highly dispersed GOD/CoFe-LDHs nano-enzyme is fabricated by immobilizing natural glucose oxidase (GOD) onto CoFe-LDHsAbstract: Currently, reactive oxygen species (ROS)-induced apoptosis systems have drawn increasing attention in cancer therapy, owing to their specific tumor inhibition ability and great biocompatibility. Herein, we developed a highly dispersed nano-enzyme based on the assembly of natural glucose oxidase (GOD) onto CoFe-layered double hydroxides (CoFe-LDHs) monolayer nanosheets. By virtue of the high dispersion of Fe 3+ within the host layer, the CoFe-LDHs nanosheets exhibit a collaborative enhanced Fenton catalytic activity with a rate constant of 3.26 × 10 −4 s −1, which is 1–3 orders of magnitude higher than other iron-containing Fenton reaction agents. Subsequently, with a massive H2 O2 triggered by GOD, GOD/CoFe-LDHs nanohybrid converts a cascade of glucose into hydroxyl radicals under tumor acid conditions, which is validated by a high maximum velocity ( V max = 2.23 × 10 −6 M) and low Michaelis–Menten constant ( K M = 5.40 mM). Through the intracellular catalytic Fenton reaction within the tumor environment, both in vitro and in vivo results demonstrate the excellent antitumor effect of GOD/CoFe-LDHs. Therefore, a self-supplied, ultra-efficient and sequential catalytic tumor-specific therapy has been achieved based on GOD/CoFe-LDHs nano-enzyme, which holds great promise in clinical cancer therapy with minimum side effects. Graphical abstract: Highly dispersed GOD/CoFe-LDHs nano-enzyme is fabricated by immobilizing natural glucose oxidase (GOD) onto CoFe-LDHs monolayer nanosheets, which provides a paradigm for cancer specific therapy through self-supplied and ultra-efficient intracellular Fenton reaction. Image 1 … (more)
- Is Part Of:
- Biomaterials. Volume 258(2020)
- Journal:
- Biomaterials
- Issue:
- Volume 258(2020)
- Issue Display:
- Volume 258, Issue 2020 (2020)
- Year:
- 2020
- Volume:
- 258
- Issue:
- 2020
- Issue Sort Value:
- 2020-0258-2020-0000
- Page Start:
- Page End:
- Publication Date:
- 2020-11
- Subjects:
- Layered double hydroxides -- Fenton reaction -- Chemodynamic therapy -- Cancer theranostic
Biomedical materials -- Periodicals
Biocompatible Materials -- Periodicals
Biomatériaux -- Périodiques
610.28 - Journal URLs:
- http://www.sciencedirect.com/science/journal/01429612 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/01429612 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/01429612 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.biomaterials.2020.120257 ↗
- Languages:
- English
- ISSNs:
- 0142-9612
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2087.715000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 15157.xml